Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
09/2007
09/27/2007US20070225325 Solid Forms of Montelukast Acid
09/27/2007US20070225318 Pyrazole Compounds Useful In The Treatment Of Inflammation
09/27/2007US20070225307 C-met modulators and method of use
09/27/2007US20070224130 Tetrahydro-Naphthalene Derivatives as Glucocorticoid Receptor Modulators
09/27/2007US20070221878 Collector for Sulfidic Ores
09/27/2007DE102006012545A1 Substituierte 2-Amino-4-phenyl-dihydrochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament Substituted 2-amino-4-phenyl-dihydroquinolines, processes for their preparation, their use as a medicament, and medicament containing them
09/27/2007CA2646541A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
09/27/2007CA2646204A1 Substituted 2-amino-4-phenyl-dihydroquinolines, method for the production thereof, use thereof as medicaments, and medicaments containing them
09/27/2007CA2645546A1 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
09/26/2007EP1837331A2 New crystalline aripiprazole salts and processes for preparation and purification thereof
09/26/2007EP1836203A2 Heteroaryl substituted quinolin-4-ylamine analogues
09/26/2007EP1836179A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
09/26/2007EP1836166A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/26/2007EP1836158A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation
09/26/2007EP1742902B1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
09/26/2007EP1302461B1 Tnf-alpha production inhibitors
09/26/2007EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation"
09/26/2007CN101044135A 喹啉衍生物 Quinoline derivatives
09/26/2007CN101044117A 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury
09/26/2007CN101041634A 3-substituted chinoline derivative and method for synthesizing same
09/26/2007CN100339360C Process for producing aromatic nitrile compound
09/25/2007US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007CA2415551C Aniline derivatives
09/20/2007WO2007106469A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007WO2007104726A1 Quinoline derivatives and their use as pesticides
09/20/2007WO2007104695A1 Quinolin-4-ylhydrazine derivatives as antimalarial agent
09/20/2007WO2007104582A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
09/20/2007WO2007036743A3 Quinolines and their therapeutic use
09/20/2007WO2006113509A3 Quinobenzoxazine analogs and methods of using thereof
09/20/2007US20070219394 Oxidizing a N-(5-alkoxy-2-methyl-4-nitrophenyl)acetamide with potassium permanganate in solution of water and a cosolvent in the presence of magnesium sulfate
09/20/2007US20070219242 oxoquinoline derivatives such as 4-[3-carboxyethyl-1,4-dihydro-1-(4-fluorophenyl)methyl-4-oxoquinolin-6-yl]-2,4-dioxobutanoic acid, ethyl ester, used for preventing or treating acquired immunodeficiency syndrome (AIDS) infection
09/20/2007US20070219231 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
09/20/2007US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both
09/20/2007US20070219203 Arylalkylamino-substituted quinazoline analogues
09/20/2007CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007CA2645376A1 Aminoquinolones as gsk-3 inhibitors
09/20/2007CA2645069A1 Quinoline derivatives and their use as pesticides
09/20/2007CA2637597A1 Tetrahydronaphthalene derivatives, processes for preparing them and their use as anti-inflammatory agents
09/19/2007EP1834948A1 Tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiinflammatory drugs
09/19/2007EP1406605B1 Carbamates of 2-heterocyclic-1,2-ethanediols
09/19/2007EP1198456B1 Potassium channel openers
09/19/2007CN101039672A Chemical compounds
09/19/2007CN101039671A Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
09/19/2007CN100338055C Carbamates of 2-heterocyclic-1, 2-ethanediols
09/19/2007CN100338038C New brand of Aripipazole, and preparation method
09/18/2007USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
09/18/2007US7271270 High affinity small molecule C5a receptor modulators
09/18/2007US7270893 Organic electroluminescent element and display
09/18/2007CA2095797C Arylacetamides
09/13/2007WO2007102771A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists
09/13/2007WO2007102512A1 Method for producing 4-oxoquinoline compound
09/13/2007WO2007102499A1 Process for production of 4-oxoquinoline compound
09/13/2007WO2007101841A2 Process for preparing a leukotriene antagonist
09/13/2007WO2007071055A8 Compositions and methods for modulating gated ion channels
09/13/2007WO2007030780A3 Quinoline derivatives and use as antitumor agents
09/13/2007US20070213484 polymerization catalyst for the polymerization of olefins; molecular weight control of polyethylene, ethylene-hexene copolymer; preparation of (2-methyl-3-pentyl-1-(8-quinolyl)cyclopentadienyl)chromium dichloride
09/13/2007US20070213365 Novel polymorphs of montelukast ammonium salts and processes for preparation therefor
09/13/2007US20070213364 Alkoxyphenylpropanoic Acid Derivatives
09/13/2007US20070213363 Tetrahydro-Quinolinylurea Derivatives
09/13/2007US20070213344 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070213343 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070213339 Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/13/2007US20070212421 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/12/2007EP1831172A1 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
09/12/2007EP1831171A1 Process for the preparation of novel amorphous montelukast sodium
09/12/2007EP1831157A2 Nonnucleoside inhibitors of hiv-1 reverse transcriptase
09/12/2007EP1253149B1 Sulfate salt of quinolonecarboxylic acid derivative and use thereof
09/12/2007EP0751926B1 Enhancement of the efficacy of drugs by deuteration
09/11/2007US7268135 Biaryl sulfonamides and methods for using same
09/11/2007CA2254066C Compounds with anti-inflammatory and immunosuppressive activities
09/07/2007WO2007099326A1 Quinoline derivatives
09/07/2007CA2642973A1 Quinoline derivatives
09/06/2007US20070208178 Reacting the side-chain precursor 1-(mercaptomethyl)cyclopropaneacetic acid (not an ester) with 2-(2-(3S)-(3-(7-chloro-2-quinolinyl)-vinylphenyl)-3-(methanesulfonyloxypropyl)phenyl-2-propanol in a basic solvent mixture; forming an amine salt; and exchanging the amine cation with sodium; 99.5+% pure
09/06/2007US20070208177 Acid addition salt of 1-(isothiuroniummethyl)cyclopropaneacetonitrile; intermediate for preparing the side-chain precursor 1-(mercaptomethyl)cyclopropaneacetic acid, which is useful in the synthesis of montelukast and salts thereof
09/06/2007US20070208166 Tao Kinase Modulators And Method Of Use
09/06/2007US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
09/05/2007EP1828154A1 Phenyl-piperazin methanone derivatives
09/05/2007EP1828137A1 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
09/05/2007EP1828136A1 (5s) -3-[(s)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as cetp inhibitors
09/05/2007EP1828135A2 Compounds and compositions as modulators of steroidal receptors and calcium channel activities
09/05/2007EP1828118A1 Parp inhibitors
09/05/2007EP1828092A1 Process and intermediate compounds useful in the preparation of statins
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007CN101031557A Substituted quinolones
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods
09/05/2007CN101029024A Production of primaquine phosphate
09/05/2007CN101029022A Process for the preparation of 4-phenoxy quinoline derivatives
09/04/2007US7265225 For therapy of cancer
09/04/2007US7265224 Red luminescent compound and organic electroluminescent device using the same
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity.
09/04/2007US7265122 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
08/2007
08/30/2007WO2007097697A1 Therapeutic quinoline compounds that are 5ht1b modulators
08/30/2007WO2007096889A2 Process for preparing montelukast and salts thereof
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 277